TrianglePUBLICATIONS · 33856405
Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- JAMA Oncol
- Publication date
- 2021 Jun 1
- First author
- Landgren O
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Landgren O
- type
- Author
- name
- Hultcrantz M
- type
- Author
- name
- Diamond B
- type
- Author
- name
- Lesokhin AM
- type
- Author
- name
- Mailankody S
- type
- Author
- name
- Hassoun H
- type
- Author
- name
- Tan C
- type
- Author
- name
- Shah UA
- type
- Author
- name
- Lu SX
- type
- Author
- name
- Salcedo M
- type
- Author
- name
- Werner K
- type
- Author
- name
- Rispoli J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Landgren O
- type
- Author
- name
- Hultcrantz M
- type
- Author
- name
- Diamond B
- type
- Author
- name
- Lesokhin AM
- type
- Author
- name
- Mailankody S
- type
- Author
- name
- Hassoun H
- type
- Author
- name
- Tan C
- type
- Author
- name
- Shah UA
- type
- Author
- name
- Lu SX
- type
- Author
- name
- Salcedo M
- type
- Author
- name
- Werner K
- type
- Author
- name
- Rispoli J
- type
- Author
- bibliography ids
- nci-bib-60c3e2a81cb29ad53275be1f
- book metadata
- content sha256
- e0857134573bbcaa8561b4811f5f1920702aad50ad5509cb0405397015da7664
- document type
- citation
- dois
- 10.1001/jamaoncol.2021.0611
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:33856405
- immutable id
- pubmed:33856405@e0857134573bbcaa8561b4811f5f1920702aad50ad5509cb0405397015da7664
- journal
- abbreviation
- JAMA Oncol
- issn electronic
- 2374-2445
- issn print
- 2374-2437
- issue
- 6
- name
- JAMA oncology
- nlm unique id
- 101652861
- pages
- 862-868
- volume
- 7
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 33856405
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- 885dc29ae8c79d97f47d900fd6a3cb7455a724bafe0faf598128b37ca672d235
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 Jun 1
- precision
- day
- year
- 2021
- publication types
- Clinical Trial
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.
Preserved source evidence · Not medical advice